Imaging · Machine learning · Clinical trials

Advanced data analytics for clinical trials

QSA applies the latest imaging and machine learning technologies to show more precisely where treatments are working, across every stage of a clinical trial.

  • Phase 1 to 4 trials
  • ISO 9001:2015 certified (BSI)

Services along the trial life cycle

From protocol design to post-trial analysis

01 · Pre-trial

Design trials that can detect change

  • Imaging protocol design and imaging charter
  • Power calculations and prognostic enrichment
  • Site selection, training and qualification
Pre-trial services

02 · During trial

Run imaging with full auditability

  • Image receipt, completeness and quality control
  • Visual reads by trained experts, for efficacy and safety
  • Quality management (ISO 9001:2015)
During-trial services

03 · Post-trial

Find where treatments work

  • Data-driven patient staging and subtyping
  • Machine-learning prognosis
  • Causal modelling and brain age
Post-trial services

Technology and biomarkers

Trial-grade tools, from image receipt to insight

Axial MRI slice with grey- and white-matter segmentation outlines
  • Automated image QC

    Machine learning that flags image issues such as blurring, ghosting and banding.

  • QSlice

    Processing pipelines with integrated quality control and interactive scan viewing.

  • QViewer

    Expert review with multi-visit comparison, lesion annotation and safety reads.

  • QSAtrophy

    Objective measurement of brain volume percentage change.

  • MindGlide

    Deep learning for rapid brain-atrophy outcomes in phase 2 and 3 trials.

  • SuStaIn

    Data-driven disease subtypes, with each patient staged within them.

Conventional biomarkers

  • Lesion number and volume
  • Whole-brain and regional volume
  • Spinal cord area and change

Advanced MRI analytics

  • MTR, DTI and NODDI, QSM, MTV
  • Slowly expanding lesions
  • Functional MRI

AI-driven stratification

  • Subtyping and staging (SuStaIn)
  • Prediction of treatment response
  • Prognostic trial enrichment

Areas of work

Neurology and beyond

  • 01

    Multiple sclerosis

    Subtyping, staging and advanced MRI biomarkers for MS trials.

  • 02

    Cell therapy

    Imaging analysis for an MS trial of a cell therapy.

  • 03

    ARIA

    An educational resource on amyloid-related imaging abnormalities.

  • 04

    Automated MRI quality control

    Machine learning that checks scans before analysis.

  • 05

    Brain fingerprinting

    DeepBrainPrint, a deep-learning method for brain fingerprinting.

  • 06

    Retinal imaging

    QSA also applies its analysis methods to retinal imaging.

Evidence

Quality you can audit

ISO 9001
Quality management system certified to ISO 9001:2015 by BSI
Phase 1–4
The full range of imaging services for clinical trials
25+ yrs
Of UCL imaging methods applied to clinical trial data
  • 2024 · Global pharmaceutical company

    A multi-year MS subtyping study through image analysis.

  • 2025 · Cell therapy

    A three-year imaging analysis for an MS trial of a CAR-T cell therapy.

Planning a clinical trial?

Tell us about your study and the imaging questions behind it.

Email enquiries@queensquareanalytics.comEmail us